Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,046.00    0.00 (0.00%)
Bid:
900.00
Ask:
0.00
Spread: 139.00 (15.444%)
Market Cap: £5.12b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

AGM trading update

19 Sep 2024 07:00

RNS Number : 7772E
Babcock International Group PLC
19 September 2024
 

 

 

 

19 September 2024

 

Babcock International Group PLC

 

AGM trading update - encouraging start to the year, FY expectations unchanged

 

Babcock International Group PLC ("Babcock" or "the Group") provides a trading update for the first five months of the financial year ahead of its Annual General Meeting to be held at 10.30 am today.

Trading update

Trading for the five-month period to 31 August 2024 has been encouraging and in line with the Board's expectations.

Positive momentum has continued into H1, and the Group has delivered good organic revenue growth, particularly in civil and naval Nuclear, and in the Land Sector. Group underlying operating profit also increased compared to the same period last year, despite last year including the license fees from the Polish MIECZNIK programme.

Our expectations for the full year are unchanged and we continue to progress toward our medium-term guidance.

Business developments

Demand in our core defence market remains positive and we continue to make good strategic progress. We have:

·

Launched H&B Defence, a joint venture with HII (NYSE: HII) to accelerate the development of critical sovereign capability for Australia's AUKUS nuclear-powered submarine programme, including workforce, nuclear infrastructure design and build, submarine defueling and decommissioning, nuclear waste and future sustainment.

·

Reopened 9 Dock in Devonport on 12 September, following the completion of an extensive regeneration project. The dry dock will deliver the £560 million maintenance programme to extend the operational life of HMS Victorious, currently underway, and is critical for the future support of the UK's Continuous At Sea Deterrent.

·

Inaugurated the Babcock Engineering & Nuclear Skills building at City College Plymouth. Opened by the Minister of State for Defence Procurement and Industry, the new facility will enhance our growing workforce's capabilities in the UK's nuclear programmes.

·

Signed a contract extension with PGZ SA, the Polish Armaments Group, to continue our support to Poland's Miecznik frigate programme until the delivery of ship three in 2031.

 

The Group's HY25 results will be published on 13 November 2024.

 

For further information:

 

Andrew Gollan, Babcock Director of Investor Relations

+44 (0)7936 039 004

Kate Hill, Babcock Group Head of Financial Communications

+44 (0)20 7355 5312

Olivia Peters / Harry Cameron, Teneo

+44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMLGRGGDZZ
Date   Source Headline
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024
17th Jul 20247:00 amRNSFY24 results update and Type 31 contract update
7th Jun 20247:00 amRNSHolding(s) in Company
26th Apr 20241:15 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.